GlassScriptPhysician profile
Harneet Singh
NPI 1972963866
$4,080.32
in general payments reported to CMS, 2019-2025
26 companies · $1,645 in 2025
The $1,645 reported for 2025 was more than what 83% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,497 · 2024: $938 · 2025: $1,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,025 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,025.33 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,745.39 | 2023-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $428.80 | 2023-2025 | Breztri, Airsupra, Tezspire |
| Genzyme Corporation | $306.54 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $255.76 | 2023-2025 | Xywav |
| Glaxosmithkline, LLC. | $194.74 | 2024-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Intuitive Surgical, INC. | $125.00 | 2024 | |
| Harmony Biosciences LLC | $118.85 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $104.15 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Zoll Respicardia, INC. | $102.68 | 2025 | Remede System |
| Philips North America LLC | $93.36 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und, (2383) Sleepundivided |
| Amgen INC. | $85.78 | 2023-2025 | Tezspire |
| Itamar Medical INC | $73.60 | 2024 | Watchpatone |
| Mylan Specialty L.P. | $58.37 | 2023-2024 | Yupelri |
| Resmed Corp | $53.10 | 2023-2025 | |
| Axsome Therapeutics, INC. | $44.68 | 2023 | Sunosi |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.41 | 2024-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Tactile Systems Technology INC | $35.44 | 2024 | Flexitouch Plus, Entre Plus |
| Insmed, INC. | $33.80 | 2025 | Arikayce |
| Baxter Healthcare | $30.18 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Optinose US, INC. | $25.59 | 2024 | |
| Shionogi INC | $22.70 | 2023 | Fetroja |
| Verona Pharma, INC. | $21.81 | 2025 | Ohtuvayre |
| Electromed, INC. | $21.70 | 2025 | Smartvest |
| Janssen Pharmaceuticals, INC | $20.65 | 2023 | Xarelto |
| Ensodata, INC. | $18.79 | 2025 | |
| Lilly USA, LLC | $15.45 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harneet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.